Molecular Biology of the Cell

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

MBC in Press, published online ahead of print November 5, 2008
Mol. Biol. Cell 10.1091/mbc.E08-04-0356

A more recent version of this article appeared on January 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Supplmental Materials
Right arrow All Versions of this Article:
E08-04-0356v1
20/1/328    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Klessner, J. L.
Right arrow Articles by Green, K. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klessner, J. L.
Right arrow Articles by Green, K. J.

Submitted on April 6, 2008
Revised on October 1, 2008
Accepted on October 29, 2008

EGFR and ADAMs Cooperate to Regulate Shedding and Endocytic Trafficking of the Desmosomal Cadherin Desmoglein 2

Jodi L. Klessner,* Bhushan V. Desai,* Evangeline V. Amargo, Spiro Getsios,{dagger} and Kathleen J. Green

Departments of Pathology and Dermatology, and the R.H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611

Monitoring Editor: Asma Nusrat

Regulation of classic cadherins plays a critical role in tissue remodeling during development and cancer; however, less attention has been paid to the importance of desmosomal cadherins. We previously showed that EGFR inhibition results in accumulation of the desmosomal cadherin, desmoglein 2 (Dsg2), at cell-cell interfaces accompanied by inhibition of matrix metalloprotease (MMP)-dependent shedding of the Dsg2 ectodomain and tyrosine phosphorylation of its cytoplasmic domain. Here, we show that EGFR inhibition stabilizes Dsg2 at intercellular junctions by interfering with its accumulation in an internalized cytoplasmic pool. Furthermore, MMP inhibition and ADAM17 RNAi, blocked shedding and depleted internalized Dsg2, but less so E-cadherin, in highly invasive SCC68 cells. ADAM9 and 15 silencing also impaired Dsg2 processing, supporting the idea that this desmosomal cadherin can be regulated by multiple ADAM family members. In contrast, ADAM10 siRNA enhanced accumulation of a 100 kDa Dsg2 cleavage product and internalized pool of Dsg2. While both MMP and EGFR inhibition increased intercellular adhesive strength in control cells, the response to MMP-inhibition was Dsg2-dependent. These data support a role for endocytic trafficking in regulating desmosomal cadherin turnover and function, and raise the possibility that internalization and regulation of desmosomal and classic cadherin function can be uncoupled mechanistically.

*These authors contributed equally to this work.

{dagger}Present adress: Departments of Dermatology, Cell and Molecular Biology, and the R.H. Lurie Cancer Center.

Address correspondence to: Kathleen J. Green (kgreen{at}northwestern.edu)






Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2008 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.